ERIC MAHLMANN: Open Payments
NPI 1043807969 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 7 payments from 6 companies in 2025. Trend: 2023 $18 · 2024 $130 · 2025 $769
Food & beverage: $755Travel & lodging: $14
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 2 | $150 |
| Phathom Pharmaceuticals, Inc. | 1 | $132 |
| Globus Medical, Inc. | 1 | $130 |
| Alkermes, Inc. | 1 | $125 |
| GENZYME CORPORATION | 1 | $123 |
| Novo Nordisk Inc | 1 | $109 |
Products named: FUROSCIX, VOQUEZNA, Senza, VIVITROL, KEVZARA, Ozempic.
Industry payments across TX — which companies pay providers there.
